Skip to main content

Beyfortus News (Page 2)

Monthly News Roundup - July 2023

FDA Clears Opill, the First Over-the-Counter (OTC) Oral Birth Control Pill History in women’s health was made in July when the FDA cleared Opill (norgestrel 0.075 mg), the first over-the-counter (...

FDA Approves Beyfortus (nirsevimab) for the Prevention of RSV Lower Respiratory Tract Disease in Infants

July 17, 2023 – AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Beyfortus patient information at Drugs.com